Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7450046rdf:typepubmed:Citationlld:pubmed
pubmed-article:7450046lifeskim:mentionsumls-concept:C0020235lld:lifeskim
pubmed-article:7450046lifeskim:mentionsumls-concept:C0039859lld:lifeskim
pubmed-article:7450046lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:7450046lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:7450046lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:7450046pubmed:issue7lld:pubmed
pubmed-article:7450046pubmed:dateCreated1981-3-24lld:pubmed
pubmed-article:7450046pubmed:abstractTextThe synthesis of 2,3-dihydro-5-formylimidazo[2,1-b]thiazoles with different substituents at position 6 (CH3, C6H5, Cl, Br) is reported; thiosemicarbazones and tosylhydrazones were prepared from these aldehydes and from the 2,3-unsaturated analogues: these derivatives, submitted to a preliminary test, did not show significant antileukemic activity.lld:pubmed
pubmed-article:7450046pubmed:languageitalld:pubmed
pubmed-article:7450046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7450046pubmed:citationSubsetIMlld:pubmed
pubmed-article:7450046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7450046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7450046pubmed:statusMEDLINElld:pubmed
pubmed-article:7450046pubmed:monthJullld:pubmed
pubmed-article:7450046pubmed:issn0430-0920lld:pubmed
pubmed-article:7450046pubmed:authorpubmed-author:AndreaniAAlld:pubmed
pubmed-article:7450046pubmed:authorpubmed-author:BonazziDDlld:pubmed
pubmed-article:7450046pubmed:authorpubmed-author:RambaldiMMlld:pubmed
pubmed-article:7450046pubmed:issnTypePrintlld:pubmed
pubmed-article:7450046pubmed:volume35lld:pubmed
pubmed-article:7450046pubmed:ownerNLMlld:pubmed
pubmed-article:7450046pubmed:authorsCompleteYlld:pubmed
pubmed-article:7450046pubmed:pagination573-80lld:pubmed
pubmed-article:7450046pubmed:dateRevised2009-6-5lld:pubmed
pubmed-article:7450046pubmed:meshHeadingpubmed-meshheading:7450046-...lld:pubmed
pubmed-article:7450046pubmed:meshHeadingpubmed-meshheading:7450046-...lld:pubmed
pubmed-article:7450046pubmed:meshHeadingpubmed-meshheading:7450046-...lld:pubmed
pubmed-article:7450046pubmed:meshHeadingpubmed-meshheading:7450046-...lld:pubmed
pubmed-article:7450046pubmed:meshHeadingpubmed-meshheading:7450046-...lld:pubmed
pubmed-article:7450046pubmed:meshHeadingpubmed-meshheading:7450046-...lld:pubmed
pubmed-article:7450046pubmed:meshHeadingpubmed-meshheading:7450046-...lld:pubmed
pubmed-article:7450046pubmed:year1980lld:pubmed
pubmed-article:7450046pubmed:articleTitle[Compounds with antitumor activity. V. Hydrazone derivatives of 5-formylimidazo(2,1-b)thiazoles and 6-substituted 2,3-dihydro-5-formylimidazo(2,1-b)thiazoles].lld:pubmed
pubmed-article:7450046pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7450046pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:7450046pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed